You need to enable JavaScript to view this site.
Skip to Content
Rankings
See All Rankings
Fortune 500
Global 500
40 Under 40
Magazine
Newsletters
Podcasts
COVID-19
More
Video On Demand
Fortune Live Media
Fortune Connect
SEARCH
SIGN IN
Bristol-Myers Squibb company profile
Fortune 500
# 115
Fortune 500
Bristol-Myers Squibb
RANK
115
Previous: 114
Next: 116
The biopharmaceutical company manufactures medicines for diseases including cancer, diabetes, and psychiatric disorders.
Regis Duvignau—Reuters
Lists ranking Bristol-Myers Squibb
RANK
487
Global 500 - 2020
This year's Global 500 generated $33.3 trillion in...
READ MORE
view in list
RANK
115
Fortune 500 - 2020
This year's Fortune 500 marks the 66th running of ...
READ MORE
view in list
Latest news for Bristol-Myers Squibb
Health
Seniors face steep drug costs as Congress stalls on capping Medicare out-of-pockets
By
Harris Meyer
and
Kaiser Health News
December 28, 2020 10:00 AM UTC
Finance
Warren Buffett is going all in on the vaccine rally, piling into these stocks
By
Katherine Chiglinsky
and
Bloomberg
November 17, 2020 10:55 AM UTC
Newsletters
Bristol Myers Squibb and Celgene got a beating in Congress on drug prices—but only Congress can fix the problem
By
Sy Mukherjee
October 1, 2020 10:28 PM UTC
Health
Diversity is long overdue in the drug industry—and it’s going to take more than just hiring Black candidates
By
Sy Mukherjee
August 12, 2020 5:08 PM UTC
Newsletters
Healthcare is in the midst of a ‘paradigm shift’
By
Alan Murray
and
Katherine Dunn
July 8, 2020 10:14 AM UTC